<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: tpiv.xfr; Date: 2015%2D06%2D19T17:26:56 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tapimmune.com/role/DocumentAndEntityInformation" xlink:href="tpiv-20150331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedBalanceSheets" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/StatementsOfOperations" xlink:href="tpiv-20150331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/StatementsOfCashFlows" xlink:href="tpiv-20150331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/NatureOfOperations" xlink:href="tpiv-20150331.xsd#NatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/BasisOfPresentation" xlink:href="tpiv-20150331.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LiquidityAndFinancialCondition" xlink:href="tpiv-20150331.xsd#LiquidityAndFinancialCondition" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="tpiv-20150331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecurities" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="tpiv-20150331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ResearchAgreements" xlink:href="tpiv-20150331.xsd#ResearchAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability" xlink:href="tpiv-20150331.xsd#DerivativeLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ConvertibleNotesPayable" xlink:href="tpiv-20150331.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LoansPayable" xlink:href="tpiv-20150331.xsd#LoansPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PromissoryNote" xlink:href="tpiv-20150331.xsd#PromissoryNote" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/RelatedPartyTransactions" xlink:href="tpiv-20150331.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStock" xlink:href="tpiv-20150331.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxes" xlink:href="tpiv-20150331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ContingenciesAndCommitments" xlink:href="tpiv-20150331.xsd#ContingenciesAndCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SubsequentEvents" xlink:href="tpiv-20150331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="tpiv-20150331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="tpiv-20150331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesTable" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecuritiesTable" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="tpiv-20150331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeWarrantLiabilityAndFairValueTables" xlink:href="tpiv-20150331.xsd#DerivativeWarrantLiabilityAndFairValueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ConvertibleNotesPayableTables" xlink:href="tpiv-20150331.xsd#ConvertibleNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockTables" xlink:href="tpiv-20150331.xsd#CapitalStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxesTables" xlink:href="tpiv-20150331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/NatureOfOperationsDetailsNarrative" xlink:href="tpiv-20150331.xsd#NatureOfOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LiquidityAndFinancialConditionDetailsNarrtive" xlink:href="tpiv-20150331.xsd#LiquidityAndFinancialConditionDetailsNarrtive" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="tpiv-20150331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesDetails" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="tpiv-20150331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="tpiv-20150331.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ResearchAgreementsDetailsNarrative" xlink:href="tpiv-20150331.xsd#ResearchAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiabilityDetails" xlink:href="tpiv-20150331.xsd#DerivativeLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiabilityDetails1" xlink:href="tpiv-20150331.xsd#DerivativeLiabilityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiabilityDetails2" xlink:href="tpiv-20150331.xsd#DerivativeLiabilityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiabilityDetails3" xlink:href="tpiv-20150331.xsd#DerivativeLiabilityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiabilityDetails4" xlink:href="tpiv-20150331.xsd#DerivativeLiabilityDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ConvertibleNotesPayableDetails" xlink:href="tpiv-20150331.xsd#ConvertibleNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="tpiv-20150331.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LoansPayableDetailsNarrative" xlink:href="tpiv-20150331.xsd#LoansPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PromissoryNotesRelatedPartyDetailsNarrative" xlink:href="tpiv-20150331.xsd#PromissoryNotesRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="tpiv-20150331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockDetails" xlink:href="tpiv-20150331.xsd#CapitalStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockDetails1" xlink:href="tpiv-20150331.xsd#CapitalStockDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockDetailsNarrative" xlink:href="tpiv-20150331.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxesDetails" xlink:href="tpiv-20150331.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxesDetails1" xlink:href="tpiv-20150331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxesDetails2" xlink:href="tpiv-20150331.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/IncomeTaxesDetailsNarrative" xlink:href="tpiv-20150331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ContingenciesAndCommitmentsDetailsNarrative" xlink:href="tpiv-20150331.xsd#ContingenciesAndCommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SubsequentEventsDetailsNarrative" xlink:href="tpiv-20150331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostconfirmationDeferredFinancingCosts" xlink:label="loc_us-gaapPostconfirmationDeferredFinancingCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPostconfirmationDeferredFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LoansAndLeasesReceivableCommercial" xlink:label="loc_us-gaapLoansAndLeasesReceivableCommercial" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansAndLeasesReceivableCommercial" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDerivatives" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDerivatives" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossBeforeTax1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossBeforeTax1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccretionOfDiscount" xlink:label="loc_us-gaapAccretionOfDiscount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapAccretionOfDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="tpiv-20150331.xsd#tpiv_InterestAndFinanceCharges" xlink:label="loc_tpivInterestAndFinanceCharges" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_tpivInterestAndFinanceCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="tpiv-20150331.xsd#tpiv_LossOnLawsuit" xlink:label="loc_tpivLossOnLawsuit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_tpivLossOnLawsuit" xlink:type="arc" weight="1" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_us-gaapCumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapCumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCharges" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="tpiv-20150331.xsd#tpiv_AccretionOfInterestOnConvertibleDebt" xlink:label="loc_tpivAccretionOfInterestOnConvertibleDebt" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_tpivAccretionOfInterestOnConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="tpiv-20150331.xsd#tpiv_NoncashInterestAndFinanceCharges" xlink:label="loc_tpivNoncashInterestAndFinanceCharges" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_tpivNoncashInterestAndFinanceCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="tpiv-20150331.xsd#tpiv_ConvertibleNotesNet" xlink:label="loc_tpivConvertibleNotesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_tpivConvertibleNotesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaapRepaymentsOfConvertibleDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfConvertibleDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentOfNotesReceivableFromRelatedParties" xlink:label="loc_us-gaapRepaymentOfNotesReceivableFromRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentOfNotesReceivableFromRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/NatureOfOperations" xlink:title="00000008 - Disclosure - NATURE OF OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/BasisOfPresentation" xlink:title="00000009 - Disclosure - BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LiquidityAndFinancialCondition" xlink:title="00000010 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecurities" xlink:title="00000012 - Disclosure - POTENTIALLY DILUTIVE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000013 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ResearchAgreements" xlink:title="00000014 - Disclosure - RESEARCH AGREEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability" xlink:title="00000015 - Disclosure - DERIVATIVE LIABILITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ConvertibleNotesPayable" xlink:title="00000016 - Disclosure - CONVERTIBLE NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LoansPayable" xlink:title="00000017 - Disclosure - LOANS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PromissoryNote" xlink:title="00000018 - Disclosure - PROMISSORY NOTES, RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/RelatedPartyTransactions" xlink:title="00000019 - Disclosure - DUE TO RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStock" xlink:title="00000020 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ContingenciesAndCommitments" xlink:title="00000022 - Disclosure - CONTINGENCIES AND COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesTable" xlink:title="00000026 - Disclosure - POTENTIALLY DILUTIVE SECURITIES (Table)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000027 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeWarrantLiabilityAndFairValueTables" xlink:title="00000028 - Disclosure - DERIVATIVE LIABILITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ConvertibleNotesPayableTables" xlink:title="00000029 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockTables" xlink:title="00000030 - Disclosure - CAPITAL STOCK (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxesTables" xlink:title="00000031 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/NatureOfOperationsDetailsNarrative" xlink:title="00000032 - Disclosure - NATURE OF OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LiquidityAndFinancialConditionDetailsNarrtive" xlink:title="00000033 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrtive)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesDetails" xlink:title="00000035 - Disclosure - POTENTIALLY DILUTIVE SECURITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="loc_us-gaapSettlementLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapSettlementLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:label="loc_us-gaapSupplementalUnemploymentBenefitsSeveranceBenefits" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapSupplementalUnemploymentBenefitsSeveranceBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000037 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ResearchAgreementsDetailsNarrative" xlink:title="00000038 - Disclosure - RESEARCH AGREEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiabilityDetails" xlink:title="00000039 - Disclosure - DERIVATIVE LIABILITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiabilityDetails1" xlink:title="00000040 - Disclosure - DERIVATIVE LIABILITY (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiabilityDetails2" xlink:title="00000041 - Disclosure - DERIVATIVE LIABILITY (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:label="loc_us-gaapDerivativeLiabilityFairValueGrossAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:to="loc_us-gaapDerivativeLiabilityFairValueGrossAsset" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiabilityDetails3" xlink:title="00000042 - Disclosure - DERIVATIVE LIABILITY (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiabilityDetails4" xlink:title="00000043 - Disclosure - DERIVATIVE LIABILITY (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ConvertibleNotesPayableDetails" xlink:title="00000044 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LoansPayableDetailsNarrative" xlink:title="00000046 - Disclosure - LOANS PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PromissoryNotesRelatedPartyDetailsNarrative" xlink:title="00000047 - Disclosure - PROMISSORY NOTES, RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000048 - Disclosure - DUE TO RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockDetails" xlink:title="00000049 - Disclosure - CAPITAL STOCK (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockDetails1" xlink:title="00000050 - Disclosure - CAPITAL STOCK (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockDetailsNarrative" xlink:title="00000051 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxesDetails" xlink:title="00000052 - Disclosure - INCOME TAXES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxesDetails1" xlink:title="00000053 - Disclosure - INCOME TAXES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxesDetails2" xlink:title="00000054 - Disclosure - INCOME TAXES (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000055 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ContingenciesAndCommitmentsDetailsNarrative" xlink:title="00000056 - Disclosure - CONTINGENCIES AND COMMITMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000057 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
